CompletedNCT00723606
What is this study about?Researchers compared Intramuscular ziprasidone mesylate and Intramuscular haloperidol, tracking side effects to assess safety and tolerability in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BaodingSchizophreniaMedication studyAges 18–65
- Countries
- China
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
CompletedNCT04655287
Official study titleDo Low Rates of Coercion in Catchment Areas Predict Negative Effects for Persons With Severe Mental Disorders? A Register Study From Norway 2015-2017. Part of Reducing Coercion in Norway (ReCoN)
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophrenia, BipolarityObservational studyAges 18–65
- Countries
- Sponsor
- University Hospital, Akershus
CompletedNCT00283517
Official study titleElectronic Schizophrenia Treatment Adherence Registry, eSTAR
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaObservational studyAges 18+
- Countries
- Sponsor
- Janssen-Cilag, S.A.
TerminatedNCT00929370
Official study titleA 4-Part Parallel Group, Randomized, Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Repeat Doses of GSK1018921 in Healthy Volunteers and Stable Patients With Schizophrenia and to Evaluate Its Effects on Pharmacokinetics of Midazolam.
This study ended early.
Multiple locations, including GlendaleSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- GlaxoSmithKline
CompletedNCT01212575
Official study titleA Retrospective, Non-interventional Study to Evaluate the Use of Seroquel XR and Seroquel IR in the Clinical Practice of Outpatients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including AabenraaSchizophreniaObservational studyAges 18–65
- Countries
- Denmark
- Sponsor
- AstraZeneca
CompletedNCT01214135
Official study titleA Retrospective, Non-interventional Study to Evaluate the Use of Seroquel XR and Seroquel IR in the Clinical Practice of Inpatients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including FalköpingSchizophreniaObservational studyAges 18–65
- Countries
- Sweden
- Sponsor
- AstraZeneca
CompletedNCT01947803
What is this study about?Researchers studied Paliperidone Palmitate, tracking side effects to assess safety and tolerability in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BaodingSchizophreniaMedication studyAges 18–65
- Countries
- China
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
CompletedNCT01150448
Official study titleAn Open-Label, Long-Term, Multiple-Dose, Safety and Tolerability, Pharmacokinetic Study of 150 mg eq. Paliperidone Palmitate in the Treatment of Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosSchizophreniaMedication studyAges 18–65
- Countries
- United States, Belgium, Croatia, + 7 others
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
CompletedNCT00119756
What is this study about?This study evaluated the safety of paliperidone palmitate for people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18+
- Countries
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
CompletedNCT00845026
What is this study about?Researchers compared LY2140023, aripiprazole, olanzapine and risperidone, tracking side effects to assess long-term safety and tolerability in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including EscondidoSchizophreniaMedication studyAges 18–65
- Countries
- United States, Germany, Mexico, + 1 other
- Sponsor
- Denovo Biopharma LLC
CompletedNCT03565068
Official study titleA Multiple-dose Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and QTc Effect of MK-8189 in Participants With Schizophrenia and Healthy Participants.
This study has finished and is no longer accepting participants.
In GlendaleSchizophreniaMedication studyAges 18–60
- Countries
- United States
- Sponsor
- Merck Sharp & Dohme LLC
CompletedNCT02205099
What is this study about?This study evaluated the safety of SKL15508 for people with schizophrenia.
This study has finished and is no longer accepting participants.
In GlendaleSchizophreniaMedication studyAges 18–60
- Countries
- United States
- Sponsor
- SK Life Science, Inc.